GLP-1 receptor agonists such as Saxenda and Wegovy work, with clinical trial evidence behind them roughly 6% and 16% body weight reduction respectively over 68-week trials
Double dosing may be allowed, if approved by a doctor
Single-cell, omics studies of human L-cells, which secrete GLP-1 and 2, may uncover regulatory networks controlling incretin secretion
Reduce | Weight Loss Drip: Help kickstart your weight loss journey with this serum that boosts metabolism, suppresses appetite, and contains fat-attracting amino acids to help your body shed fat
Nrgaard CH, Friedrich S, Hansen CT, Gerds T, Ballard C, Mller DV, et al
An EKG ensures safe prescribing and monitoring